Cargando…

Depressive effectiveness of vigabatrin (γ-vinyl-GABA), an antiepileptic drug, in intermediate-conductance calcium-activated potassium channels in human glioma cells

BACKGROUND: Vigabatrin (VGB) is an approved non-traditional antiepileptic drug that has been revealed to have potential for treating brain tumors; however, its effect on ionic channels in glioma cells remains largely unclear. METHODS: With the aid of patch-clamp technology, we investigated the effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Te-Yu, Huang, Huai-Ying Ingrid, Wu, Sheng-Nan, Huang, Chin-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807716/ https://www.ncbi.nlm.nih.gov/pubmed/33441172 http://dx.doi.org/10.1186/s40360-021-00472-3

Ejemplares similares

Intestinal absorption of the antiepileptic drug substance vigabatrin is altered by infant formula in vitro and in vivo.
por: Nøhr, Martha Kampp, et al.
Publicado: (2014)

Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use‐limiting visual field defects
por: Walters, Dana C., et al.
Publicado: (2019)

Effects of GABA and Vigabatrin on the Germination of Chinese Chestnut Recalcitrant Seeds and Its Implications for Seed Dormancy and Storage
por: Du, Changjian, et al.
Publicado: (2020)

Response to sequential treatment with prednisolone and vigabatrin in infantile spasms
por: Dzau, Winston, et al.
Publicado: (2022)

The Discordance between Network Excitability and Cognitive Performance Following Vigabatrin Treatment during Epileptogenesis
por: Lai, Ming-Chi, et al.
Publicado: (2021)

Characterization of Convergent Suppression by UCL-2077 (3-(Triphenylmethylaminomethyl)pyridine), Known to Inhibit Slow Afterhyperpolarization, of erg-Mediated Potassium Currents and Intermediate-Conductance Calcium-Activated Potassium Channels
por: Hsu, Hung-Te, et al.
Publicado: (2020)

Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma
por: Catacuzzeno, Luigi, et al.
Publicado: (2012)

Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain
por: Pedarzani, P., et al.
Publicado: (2008)

Safety and Efficacy of Vigabatrin for the Treatment of Infantile Spasms
por: Faulkner, Michele A., et al.
Publicado: (2011)

Intermediate-Conductance-Ca2-Activated K Channel Intermediate-Conductance Calcium-Activated Potassium Channel (IKCa1) is Upregulated and Promotes Cell Proliferation in Cervical Cancer
por: Liu, Ling, et al.
Publicado: (2017)

Intermediate Conductances during Deactivation of Heteromultimeric Shaker Potassium Channels
por: Zheng, Jie, et al.
Publicado: (1998)

Treatment of refractory complex partial seizures: role of vigabatrin
por: Waterhouse, Elizabeth J, et al.
Publicado: (2009)

Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010)

Vigabatrin and Visual Field Defects in Pediatric Epilepsy Patients
por: You, Su Jeong, et al.
Publicado: (2006)

Towards a Synthesis of Vigabatrin Using Glycal Chemistry
por: Boga, Sobhana B., et al.
Publicado: (2005)

Antiepileptic activity and subtype-selective action of flupirtine at GABA(A) receptors
por: Bajrić, Mirnes, et al.
Publicado: (2012)

Functional characterization of the antiepileptic drug candidate, padsevonil, on GABA(A) receptors
por: Niespodziany, Isabelle, et al.
Publicado: (2020)

Early vigabatrin augmenting GABA-ergic pathways in post-anoxic status epilepticus (VIGAB-STAT) phase IIa clinical trial study protocol
por: Maciel, Carolina B., et al.
Publicado: (2022)

Control of hypothalamic–pituitary–adrenal stress axis activity by the intermediate conductance calcium-activated potassium channel, SK4
por: Liang, Zhi, et al.
Publicado: (2011)

Inactivation of Endothelial Small/Intermediate Conductance of Calcium-Activated Potassium Channels Contributes to Coronary Arteriolar Dysfunction in Diabetic Patients
por: Liu, Yuhong, et al.
Publicado: (2015)

The intermediate‐conductance calcium‐activated potassium channel KCa3.1 contributes to alkalinization‐induced vascular calcification in vitro
por: Bai, Yaling, et al.
Publicado: (2021)

LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells
por: Caglioti, Concetta, et al.
Publicado: (2022)

Small and Intermediate Calcium-Activated Potassium Channel Openers Improve Rat Endothelial and Erectile Function
por: Comerma-Steffensen, Simon G., et al.
Publicado: (2017)

Hypoxic Regulation of the Large-Conductance, Calcium and Voltage-Activated Potassium Channel, BK
por: Ochoa, Sara V., et al.
Publicado: (2021)

Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
por: Tolman, Justin A, et al.
Publicado: (2011)

Clinical Trial of Vigabatrin as Adjunctive Therapy in Children with Refractory Epilepsy
por: Taghdiri, Mohammad-Mahdi, et al.
Publicado: (2013)

Electrophysiological network predicts clinical response to vigabatrin in epileptic spasms
por: Kim, Junhyung, et al.
Publicado: (2023)

Blocking Intermediate-Conductance Calcium-Activated Potassium Channels in the Macrophages Around Ganglionated Plexi Suppresses Atrial Fibrillation Vulnerability in Canines With Rapid Atrial Pacing
por: Ma, Yazhe, et al.
Publicado: (2022)

TRAM-34, a Putatively Selective Blocker of Intermediate-Conductance, Calcium-Activated Potassium Channels, Inhibits Cytochrome P450 Activity
por: Agarwal, Jay J., et al.
Publicado: (2013)

Peptide Lv augments intermediate-conductance calcium-dependent potassium channels (K(Ca)3.1) in endothelial cells to promote angiogenesis
por: Pham, Dylan L., et al.
Publicado: (2022)

Oxidative Regulation of Large Conductance Calcium-Activated Potassium Channels
por: Tang, Xiang D., et al.
Publicado: (2001)

The conduction velocity-potassium relationship in the heart is modulated by sodium and calcium
por: King, D. Ryan, et al.
Publicado: (2021)

Vigabatrin-Induced Generalized Epileptiform Discharges in a Patient with Focal Epilepsy
por: Kwon, Oh-Young, et al.
Publicado: (2012)

Torin 1 partially corrects vigabatrin-induced mitochondrial increase in mouse
por: Vogel, Kara R, et al.
Publicado: (2015)

Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study
por: Westall, Carol A., et al.
Publicado: (2014)

A Case of Vigabatrin Toxicity Mimicking Bilateral Thalamic Infarcts on MRI
por: Lockard, Trevor J, et al.
Publicado: (2023)

Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin
por: Boothman, Isabelle, et al.
Publicado: (2023)

A functional role for both γ-aminobutyric acid (GABA) transporter-1 and GABA transporter-3 in the modulation of extracellular GABA and GABAergic tonic conductances in the rat hippocampus
por: Kersanté, Flavie, et al.
Publicado: (2013)

A New Chemoenzymatic Synthesis of the Chiral Key Intermediate of the Antiepileptic Brivaracetam
por: Ciceri, Samuele, et al.
Publicado: (2018)

Vigabatrin-Induced Retinal Toxicity Is Partially Mediated by Signaling in Rod and Cone Photoreceptors
por: Yang, Jin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0mlsg9kq5p47jb6uicsp3outqs